A new series of Pokémon Sketch graphic tee designs for both kids and adults are set to hit Uniqlo in the U.S. this April.

Chief Minister Nayab Singh Saini today asserted that the political atmosphere in the state strongly favours the BJP, predicting that the Congress will fail to win even a single seat in the civic ...

Nottingham (United Kingdom) (AFP) – Arsenal's Premier League title challenge suffered another damaging blow after they were shut out by Nottingham Forest in a 0-0 stalemate on Wednesday. The ...

Arsenal's Premier League title challenge suffered another damaging blow after they were shut out by Nottingham Forest in a 0-0 stalemate on Wednesday. The Gunners' lack of forward options due to a ...

The draw sees third-place Nottingham Forest’s hopes of Champions League qualification still firmly on track and they remain two points clear of Chelsea in fifth spot. Arsenal returns to action on ...

Arsenal’s Brazilian defender #06 Gabriel Magalhaes reacts at the end of during the English Premier League football match between Nottingham Forest and Arsenal at The City Ground in Nottingham ...

They battled away but failed to score for the third successive match in a goalless draw at Vauxhall Road. Riley Court battles with his man down the right. Picture: Helen Cooper It’s now three ...

Amid the loss in Haryana and Delhi elections, the grand old party Congress has made reshuffle in the organization. Congress has entrusted major responsibilities to many senior and experienced leaders ...

(Photo by INA FASSBENDER / AFP) A dogged defensive performance from Bayern Munich kept Bayer Leverkusen at bay in a 0-0 away draw on Saturday to keep their eight-point lead atop the German Bundesliga.

One lucky punter is waking up a millionaire this morning after they scooped a whipping €1,005,000 in last night’s EuroMillions Ireland Only Raffle draw. The National Lottery has revealed that the ...

Novartis/Incyte’s Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against COVID-19, after it failed to cut complications or death in a phase 3 trial.